← Back
$CRNX All transactions

Crinetics Pharmaceuticals, Inc.

▼ SELL 10b5-1 Plan

$ Value

$160K

Shares

4,241

Price

$38

Filed

Mar 18

Insider

Name

Betz Stephen F.

Title

Chief Scientific Officer

CIK

0001886575

Roles

Officer

Transaction Details

Transaction Date

2026-03-16

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

137,101

Footnotes

Represents the number of shares of common stock sold by the Issuer to cover the Reporting Person's tax withholding obligation upon the vesting of Restricted Stock Units granted on February 28, 2022, March 1, 2023, March 4, 2024, and February 20, 2025. The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person. | The common stock was sold in open market transactions on the transaction date, with a volume weighted average sales price of $37.11 per share. The range of sales prices on the transaction date was $36.42 to $37.38 per share. Detailed information on the exact number of shares can be obtained from the Issuer upon request. | The common stock was sold in open market transactions on the transaction date, with a volume weighted average sales price of $37.77 per share. The range of sales prices on the transaction date was $37.42 to $38.23 per share. Detailed information on the exact number of shares can be obtained from the Issuer upon request.

Filing Info

Accession No.

0001628280-26-019498

Form Type

4

Issuer CIK

0001658247

Betz Stephen F.'s History

Date Ticker Type Value
2026-03-16 CRNX $236K
2026-03-16 CRNX $160K
2026-02-23 CRNX A $0
2026-02-23 CRNX A $0
2025-12-26 CRNX M $34K
2025-12-26 CRNX M $0
2025-06-12 CRNX M $137K
2025-06-12 CRNX M $154K
2025-06-12 CRNX $3.1M
2025-06-12 CRNX M $0

Other Insiders at CRNX (90d)

Insider Bought Sold Last
Vivaldi Coelho Rogerio $181K 2026-03-12
Schilke Tobin
Chief Financial Officer
$266K 2026-03-03
Okey Stephanie $119K 2026-03-03
Struthers Richard Scott
President & CEO
$822K 2026-03-16
Knight Jeff E.
Chief Dev. & Operating Officer
$3.4M 2026-04-08
Knight Jeff E.
Chief Operating Officer
$370K 2026-03-16
Betz Stephen F.
Chief Scientific Officer
$236K 2026-03-16
Kalofonos Isabel
Chief Commercial Officer
2026-02-23